Physician

Christopher Jordon Gee, M.D.

According to 2025 Medicare claims, Christopher Gee, M.D. (NPI: 1831372499) practices ophthalmology in the Salt Lake City-Murray, UT market, with the plurality of this provider's patient population coming from Salt Lake, UT. This provider's primary affiliated billing organization is SALT LAKE RETINA, LLC (NPI: 1144622234; TIN: 47-1293676) and primary practice location at 84088-5561.

Gee's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 547 traditional Medicare patients, billed 38,728 HCPCS/CPT codes, and received $2,090,911 in Medicare payments. The top billing code was 92235 (Exam of retinal blood vessels using a special camera after injection of a dye). Part D data shows 383 prescription claims across 169 beneficiaries totaling $11,108 in drug costs, led by Prednisolone Acetate (Prednisolone Acetate). Open Payments data shows 28 records totaling $713. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $928,544 to $2,090,911. Concurrently, Part D prescription costs did not follow a clear longitudinal pattern. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$1.0M$2.1M2015 Medicare payment: $928,544 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $1,115,350 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $1,199,569 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $1,444,146 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $1,486,196 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $1,481,357 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $1,554,257 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $1,704,750 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $1,980,663 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $2,090,911 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20153385,319$928,544
20163626,080$1,115,350
20173936,097$1,199,569
20184577,468$1,444,146
20194907,626$1,486,196
20204427,617$1,481,357
20214507,870$1,554,257
202252216,849$1,704,750
202353736,819$1,980,663
202454738,728$2,090,911

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$12K$23K2015 Drug cost: $20,329 (USD; Tot_Drug_Cst)2016 Drug cost: $23,081 (USD; Tot_Drug_Cst)2017 Drug cost: $20,533 (USD; Tot_Drug_Cst)2018 Drug cost: $19,577 (USD; Tot_Drug_Cst)2019 Drug cost: $20,375 (USD; Tot_Drug_Cst)2020 Drug cost: $16,272 (USD; Tot_Drug_Cst)2021 Drug cost: $16,681 (USD; Tot_Drug_Cst)2022 Drug cost: $19,701 (USD; Tot_Drug_Cst)2023 Drug cost: $21,202 (USD; Tot_Drug_Cst)2024 Drug cost: $11,108 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015111314$20,329
2016108295$23,081
2017105286$20,533
2018115339$19,577
2019114326$20,375
2020110327$16,272
2021102312$16,681
2022142372$19,701
2023165425$21,202
2024169383$11,108

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
92235Exam of retinal blood vessels using a special camera after injection of a dye145150$116
67028Injection of drug into eye1941,033$87
92014Established patient complete exam of visual system411640$77
92134Imaging of retina4841,378$29
92250Photography of the retina202263$26

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Prednisolone AcetatePrednisolone Acetate1152,672$3,984
MoxifloxacinMoxifloxacin Hcl811,100$1,839
Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat392,564$426
Diclofenac SodiumDiclofenac Sodium27579$343
LatanoprostLatanoprost442,508$300

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.28$713Regeneron Healthcare Solutions, Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Christopher Jordon Gee, M.D.?

Tedicare shows public-source Medicare data for Christopher Jordon Gee, M.D. (NPI 1831372499), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Christopher Jordon Gee, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Christopher Jordon Gee, M.D.?

Christopher Jordon Gee, M.D. is linked to SALT LAKE RETINA, LLC (billing NPI 1144622234) in the available physician profile data.

Does Christopher Jordon Gee, M.D. have Open Payments data?

Christopher Jordon Gee, M.D. has 28 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.